Novartis digs deeper into cancer with up to $750 mln Aduro deal
March 30, 2015 at 04:06 AM EDT
March 30 (Reuters) - Swiss drugmaker Novartis is digging deeper into the world of cancer immunotherapy - one of the hottest areas of drug research - through a tie-up with California-based Aduro Biotech worth up to $750 million.